Search results (58)
« Back to PublicationsCauses of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.
Journal article
Challenger A. et al, (2026), Blood Adv
Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis.
Journal article
Banjanin B. et al, (2026), Hemasphere, 10
Unsupervised Discovery of Spatiotypes and Context-Aware Graph Neural Networks for Modeling Clinical Endpoints
Chapter
Dawood M. et al, (2026), 15970 LNCS, 603 - 612
Redefining the topology of the human bone marrow using augmented spatial transcriptomic analysis
Preprint
Cooper RA. et al, (2025)
Using optical skyrmions to assess vectorial adaptive optics capabilities in the presence of complex aberrations.
Journal article
Ma Y. et al, (2025), Sci Adv, 11
Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F-positive MPNs in vivo.
Journal article
Papadopoulos N. et al, (2025), Blood, 146, 482 - 495
econfigurable arbitrary retarder array as complex structured matter.
Journal article
He C. et al, (2025), Nat Commun, 16
Reticulin-Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications.
Journal article
Ryou H. et al, (2025), EJHaem, 6
Spatial transcriptomic approaches for characterising the bone marrow landscape: pitfalls and potential.
Journal article
Cooper RA. et al, (2025), Leukemia, 39, 291 - 295
Entering the era of spatial transcriptomics: opportunities and challenges for pathology
Journal article
Sozanska AM. et al, (2025), Diagnostic Histopathology
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.
Journal article
Li R. et al, (2024), Sci Transl Med, 16
Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice.
Journal article
Godfrey AL. et al, (2024), Br J Haematol, 205, 1411 - 1416
Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentraxin alfa.
Journal article
Ryou H. et al, (2024), Hemasphere, 8
Nasopharyngeal myeloid sarcoma as a manifestation of acute monomyelocytic leukaemia.
Journal article
Pervaiz A. et al, (2023), BMJ Case Rep, 16
